NR4A1 and breast carcinoma: Consistent DFS, BCSS, and OS results as in the entire cohort were observed between BRCA1 and BRCA2 carriers with hormone receptor–positive (Data Supplement, Fig S2) and hormone receptor–negative breast cancers (Data Supplement, Fig S3).